...
首页> 外文期刊>Journal of Electroanalytical Chemistry: An International Journal Devoted to All Aspects of Electrode Kinetics, Interfacial Structure, Properties of Electrolytes, Colloid and Biological Electrochemistry >Triggered hairpin switch and in situ nonlinear hybridization chain reaction enabling label-free electrochemiluminescent detection of BCR/ABL fusion gene
【24h】

Triggered hairpin switch and in situ nonlinear hybridization chain reaction enabling label-free electrochemiluminescent detection of BCR/ABL fusion gene

机译:触发发夹开关和原位非线性杂交链反应,可实现BCR / Abl融合基因的无标记电化学检测

获取原文
获取原文并翻译 | 示例

摘要

AbstractHerein, a highly specific and ultrasensitive strategy is presented for label-free electrochemiluminescent (ECL) detection of BCR/ABL fusion gene via triggered hairpin switch and in situ nonlinear hybridization chain reaction (HCR) signal amplification. A droplet of mixture containing nonlinear HCR system is dropped on the gold electrode surface modified with capture probes, in which a trigger DNA in the hairpin switch initiates self-sustained assembly of double-stranded substrates into dendritic nanostructures. The presence of BCR/ABL fusion gene leads to the open of hairpin switch and the growth of dendritic nanostructures onto electrode surface. The dsDNA grooves of the nanostructures bind with numerous ECL signal indicators Ru(phen)32+, resulting in exponential amplification of ECL signal output. The developed biosensor achieves a low detection limit of 5.49fM towards BCR/ABL fusion gene, and can distinguish single base-mismatched target. And the biosensor further applied in complex matrix without the decline of analytical performance. In addition, this method has the advantages of enzyme-free and label-free assay system. These advantages make the sensor be a promising candidate in the determination of fusion gene for medical diagnostics.Highlights?The strategy reengineers in situ nonlinear hybridization reaction with a hairpin switch for electrochemiluminescent detection.?The biosensing strategy attains specific and ultrasensitive detection of BCR/ABL fusion gene.?The method achieves enzyme-free, label-free and low-cost detection without the attending protein or nanoparticles.?This simple method is compatible with point of care testing.]]>
机译:<![cdata [ 抽象 本文,呈现了高度特定和超细策略的BCR / ABL的无标记电化学发光(ECL)检测融合基因通过触发发夹开关和原位非线性杂交链反应(HCR)信号放大。含有非线性HCR系统的混合物的液滴在用捕获探针改性的金电极表面上滴下,其中发夹开关中的触发DNA引发了双链底物的自持组装成树突纳米结构。 BCR / Abl融合基因的存在导致发夹开关的开放和树突式纳米结构的生长到电极表面上。纳米结构的DSDNA凹槽与无数ECL信号指示器Ru(Pen) 3 2 + ,导致ECL信号输出的指数放大。开发的生物传感器朝向BCR / ABL融合基因的低检测限为5.49fm,并且可以区分单一的基匹配目标。并且生物传感器进一步应用于复杂的基质,而不会下降分析性能。此外,该方法具有无酶和无标记的测定系统的优点。这些优点使传感器成为医疗诊断融合基因的有希望的候选者。 突出显示 < CE:PARA ID =“P0005”视图=“全部”>策略再造者与发夹电影开关的原位非线性杂交反应,用于电化学发光检测。 生物传感策略达到BCR / Abl融合基因的特异性和超声检测。 该方法在没有参加蛋白质或纳米颗粒的情况下实现无酶,无标记和低成本检测。 这个简单的方法与护理点测试兼容。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号